Delivery Order SPE2DB20D3103-SPE2DB25FP8R6
Award Date 8/13/25
Potential Completion Date 8/14/25
Potential Value $134K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $16,140.89. This delivery order represents a firm fixed price contract with no set-aside designation, utilizing open and competitive procurement practices. The contract is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $3,176.22 and a completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a $1,252.42 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and is scheduled for completion by July 25, 2025,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $3,914.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a non-set-aside competitive award representing a child order under AmerisourceBergen's larger contract vehicle with DLA. Vemlidy is an antiviral medication, and this delivery order reflects AmerisourceBergen's role as a critical pharmaceutical supplier supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $21,823.23. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is scheduled for ultimate completion on July 24, 2025, with performance to be conducted at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,919.85 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,405.94 to AmerisourceBergen Drug Corp for 30 tablets of Vemlidy 25 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance to be completed at the contractor's Conshohocken, Pennsylvania facility. The contract is a child award under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract...